IL-21

interleukin-21 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-21, covering 2023-08-14 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of IL-21 to Treat Metastatic Melanoma [Phase 2]